FindTrial
Sign In

Drug utilization study of Gastric acid reducing agents in patients hospitalized at tertiary care Centre

Drug utilization study of Gastric acid reducing agents in patients hospitalized at tertiary care Centre: A cross sectional descriptive study - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2025/11/097354
Enrollment
459
Registered
2025-11-13
Start date
Unknown
Completion date
Unknown
Last updated
2025-11-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K929- Disease of digestive system, unspecified

Interventions

Intervention1: Nil: Nil

Sponsors

NIL
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Age 18-80 years of age, both Male and female patients on Gastric acid reducing agents along with other concomitant drugs

Exclusion criteria

Exclusion criteria: Patients who will not give consent to review file

Design outcomes

Primary

MeasureTime frame
To analyze the utilization pattern of gastric acid reducing drugs in the IPD patients of tertiary care centerTimepoint: 1 year—

Secondary

MeasureTime frame
1) To analyze rationality of prescribed gastric acid reducing agents in the hospitalized patients in tertiary care center 2) To evaluate the drug interactions of gastric acid reducing drugs among indoor patients of tertiary care hospital Timepoint: 1 year—

Countries

India

Contacts

Public ContactDr Pallawi Shashank Khatavkar

Bharati Vidyapeeth (DTU) Medical College Pune

pallavi.khatavkar@bharatividyapeeth.edu9921393456

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026